Boston Scientific Corp (BSX)
73.15
-0.11
(-0.15%)
USD |
NYSE |
Apr 26, 16:00
73.15
0.00 (0.00%)
After-Hours: 18:04
Boston Scientific Cash from Financing (TTM): 5.00M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 5.00M |
| September 30, 2023 | -9.00M |
| June 30, 2023 | -224.00M |
| March 31, 2023 | -611.00M |
| December 31, 2022 | -548.00M |
| September 30, 2022 | -557.00M |
| June 30, 2022 | -352.00M |
| March 31, 2022 | -6.00M |
| December 31, 2021 | -95.00M |
| September 30, 2021 | -906.00M |
| June 30, 2021 | -1.161B |
| March 31, 2021 | -58.00M |
| December 31, 2020 | 293.00M |
| September 30, 2020 | 388.00M |
| June 30, 2020 | 1.951B |
| March 31, 2020 | 1.102B |
| December 31, 2019 | 2.973B |
| September 30, 2019 | 4.122B |
| June 30, 2019 | 2.959B |
| March 31, 2019 | 3.429B |
| December 31, 2018 | 1.432B |
| September 30, 2018 | 939.00M |
| June 30, 2018 | 649.00M |
| March 31, 2018 | 255.00M |
| December 31, 2017 | 110.00M |
| Date | Value |
|---|---|
| September 30, 2017 | 206.00M |
| June 30, 2017 | 379.00M |
| March 31, 2017 | -170.00M |
| December 31, 2016 | -206.00M |
| September 30, 2016 | -471.00M |
| June 30, 2016 | 256.00M |
| March 31, 2016 | 1.319B |
| December 31, 2015 | 1.276B |
| September 30, 2015 | 1.499B |
| June 30, 2015 | 756.00M |
| March 31, 2015 | -84.00M |
| December 31, 2014 | -150.00M |
| September 30, 2014 | -401.00M |
| June 30, 2014 | -557.00M |
| March 31, 2014 | -670.00M |
| December 31, 2013 | -624.00M |
| September 30, 2013 | -621.00M |
| June 30, 2013 | -722.00M |
| March 31, 2013 | -746.00M |
| December 31, 2012 | -764.00M |
| September 30, 2012 | -810.00M |
| June 30, 2012 | -750.00M |
| March 31, 2012 | -1.369B |
| December 31, 2011 | -1.728B |
| September 30, 2011 | -2.029B |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-1.161B
Minimum
Jun 2021
4.122B
Maximum
Sep 2019
487.68M
Average
-9.00M
Median
Sep 2023
Cash from Financing (TTM) Benchmarks
| Stryker Corp | -1.594B |
| Abbott Laboratories | -7.091B |
| Edwards Lifesciences Corp | -711.00M |
| Intuitive Surgical Inc | 46.90M |
| Axonics Inc | -3.38M |